Suven Pharmaceuticals announces board meeting to approve audited results

Suven Pharmaceuticals (BSE: SUVENPHAR) has announced that a meeting of its Board of Directors is scheduled for Wednesday, May 28, 2025. The primary agenda is to consider and approve the audited financial results for the quarter and financial year ending March 31, 2025. The company also stated that in accordance with SEBI regulations concerning insider trading, the trading window for company securities will be closed from April 1, 2025, to May 30, 2025, inclusive. This information was formally disclosed to the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE).